October 23, 2009

onepharm focusses on periodontal disease and spins out anti-viral research and together with EMBL founds Savira Pharmaceuticals

June 25, 2009

onepharm recently received approval from the BfArM, the German health authority, for the execution of a double-blind, placebo-controlled clinical phase 2 study in periodontal disease.

April 02, 2009

Combining EMBL's structural biology research and onepharm' established in-vitro and in-vivo screening tools for evaluating anti-viral activity, novel influenza anti-viral drugs directed against the viral polymerase will be...

March 09, 2009

onepharm aquires a patent from WuHan Huana Biological Engineering Company covering the use of OPM-3023 in IBD, based on a co-development of WuHana and the pharmaceutical department of the WuHan University, a leading Chinese...

May 28, 2008

Working with its collaboration partner, The Forsyth Institute (Boston, MA), onepharm has successfully confirmed the inhibition of bone loss in periodontitis...